Lenvatinib-Global Market Status & Trend Report 2015-2026 Top 20 Countries Data
Report Summary
Lenvatinib-Global Market Status & Trend Report 2015-2026 Top 20 Countries Data offers a comprehensive analysis on Lenvatinib industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Lenvatinib 2015-2019, and development forecast 2020-2026
Main manufacturers/suppliers of Lenvatinib worldwide and market share by regions, with company and product introduction, position in the Lenvatinib market
Market status and development trend of Lenvatinib by types and applications
Cost and profit status of Lenvatinib, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Lenvatinib market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Lenvatinib industry.
The report segments the global Lenvatinib market as:
Global Lenvatinib Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Lenvatinib Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
4mg
10mg
Global Lenvatinib Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Hospital
Pharmacy
Other
Global Lenvatinib Market: Manufacturers Segment Analysis (Company and Product introduction, Lenvatinib Sales Volume, Revenue, Price and Gross Margin):
Eisai Co.
Everest Medicines
Beacon Pharmaceuticals Limited
Shilpa Medicare Ltd.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Lenvatinib-Global Market Status & Trend Report 2015-2026 Top 20 Countries Data offers a comprehensive analysis on Lenvatinib industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Lenvatinib 2015-2019, and development forecast 2020-2026
Main manufacturers/suppliers of Lenvatinib worldwide and market share by regions, with company and product introduction, position in the Lenvatinib market
Market status and development trend of Lenvatinib by types and applications
Cost and profit status of Lenvatinib, and marketing status
Market growth drivers and challengesSince the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency.The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Ammonium Lenvatinib market in 2020.COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.This report also analyses the impact of Coronavirus COVID-19 on the Lenvatinib industry.
The report segments the global Lenvatinib market as:
Global Lenvatinib Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2015-2026):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Lenvatinib Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2015-2026):
4mg
10mg
Global Lenvatinib Market: Application Segment Analysis (Consumption Volume and Market Share 2015-2026; Downstream Customers and Market Analysis)
Hospital
Pharmacy
Other
Global Lenvatinib Market: Manufacturers Segment Analysis (Company and Product introduction, Lenvatinib Sales Volume, Revenue, Price and Gross Margin):
Eisai Co.
Everest Medicines
Beacon Pharmaceuticals Limited
Shilpa Medicare Ltd.
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF LENVATINIB
1.1 Definition of Lenvatinib in This Report
1.2 Commercial Types of Lenvatinib
1.2.1 4mg
1.2.2 10mg
1.3 Downstream Application of Lenvatinib
1.3.1 Hospital
1.3.2 Pharmacy
1.3.3 Other
1.4 Development History of Lenvatinib
1.5 Market Status and Trend of Lenvatinib 2015-2026
1.5.1 Global Lenvatinib Market Status and Trend 2015-2026
1.5.2 Regional Lenvatinib Market Status and Trend 2015-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Lenvatinib 2015-2019
2.2 Sales Market of Lenvatinib by Regions
2.2.1 Sales Volume of Lenvatinib by Regions
2.2.2 Sales Value of Lenvatinib by Regions
2.3 Production Market of Lenvatinib by Regions
2.4 Global Market Forecast of Lenvatinib 2020-2026
2.4.1 Global Market Forecast of Lenvatinib 2020-2026
2.4.2 Market Forecast of Lenvatinib by Regions 2020-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Lenvatinib by Types
3.2 Sales Value of Lenvatinib by Types
3.3 Market Forecast of Lenvatinib by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Lenvatinib by Downstream Industry
4.2 Global Market Forecast of Lenvatinib by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Lenvatinib Market Status by Countries
5.1.1 North America Lenvatinib Sales by Countries (2015-2019)
5.1.2 North America Lenvatinib Revenue by Countries (2015-2019)
5.1.3 United States Lenvatinib Market Status (2015-2019)
5.1.4 Canada Lenvatinib Market Status (2015-2019)
5.1.5 Mexico Lenvatinib Market Status (2015-2019)
5.2 North America Lenvatinib Market Status by Manufacturers
5.3 North America Lenvatinib Market Status by Type (2015-2019)
5.3.1 North America Lenvatinib Sales by Type (2015-2019)
5.3.2 North America Lenvatinib Revenue by Type (2015-2019)
5.4 North America Lenvatinib Market Status by Downstream Industry (2015-2019)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Lenvatinib Market Status by Countries
6.1.1 Europe Lenvatinib Sales by Countries (2015-2019)
6.1.2 Europe Lenvatinib Revenue by Countries (2015-2019)
6.1.3 Germany Lenvatinib Market Status (2015-2019)
6.1.4 UK Lenvatinib Market Status (2015-2019)
6.1.5 France Lenvatinib Market Status (2015-2019)
6.1.6 Italy Lenvatinib Market Status (2015-2019)
6.1.7 Russia Lenvatinib Market Status (2015-2019)
6.1.8 Spain Lenvatinib Market Status (2015-2019)
6.1.9 Benelux Lenvatinib Market Status (2015-2019)
6.2 Europe Lenvatinib Market Status by Manufacturers
6.3 Europe Lenvatinib Market Status by Type (2015-2019)
6.3.1 Europe Lenvatinib Sales by Type (2015-2019)
6.3.2 Europe Lenvatinib Revenue by Type (2015-2019)
6.4 Europe Lenvatinib Market Status by Downstream Industry (2015-2019)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Lenvatinib Market Status by Countries
7.1.1 Asia Pacific Lenvatinib Sales by Countries (2015-2019)
7.1.2 Asia Pacific Lenvatinib Revenue by Countries (2015-2019)
7.1.3 China Lenvatinib Market Status (2015-2019)
7.1.4 Japan Lenvatinib Market Status (2015-2019)
7.1.5 India Lenvatinib Market Status (2015-2019)
7.1.6 Southeast Asia Lenvatinib Market Status (2015-2019)
7.1.7 Australia Lenvatinib Market Status (2015-2019)
7.2 Asia Pacific Lenvatinib Market Status by Manufacturers
7.3 Asia Pacific Lenvatinib Market Status by Type (2015-2019)
7.3.1 Asia Pacific Lenvatinib Sales by Type (2015-2019)
7.3.2 Asia Pacific Lenvatinib Revenue by Type (2015-2019)
7.4 Asia Pacific Lenvatinib Market Status by Downstream Industry (2015-2019)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Lenvatinib Market Status by Countries
8.1.1 Latin America Lenvatinib Sales by Countries (2015-2019)
8.1.2 Latin America Lenvatinib Revenue by Countries (2015-2019)
8.1.3 Brazil Lenvatinib Market Status (2015-2019)
8.1.4 Argentina Lenvatinib Market Status (2015-2019)
8.1.5 Colombia Lenvatinib Market Status (2015-2019)
8.2 Latin America Lenvatinib Market Status by Manufacturers
8.3 Latin America Lenvatinib Market Status by Type (2015-2019)
8.3.1 Latin America Lenvatinib Sales by Type (2015-2019)
8.3.2 Latin America Lenvatinib Revenue by Type (2015-2019)
8.4 Latin America Lenvatinib Market Status by Downstream Industry (2015-2019)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Lenvatinib Market Status by Countries
9.1.1 Middle East and Africa Lenvatinib Sales by Countries (2015-2019)
9.1.2 Middle East and Africa Lenvatinib Revenue by Countries (2015-2019)
9.1.3 Middle East Lenvatinib Market Status (2015-2019)
9.1.4 Africa Lenvatinib Market Status (2015-2019)
9.2 Middle East and Africa Lenvatinib Market Status by Manufacturers
9.3 Middle East and Africa Lenvatinib Market Status by Type (2015-2019)
9.3.1 Middle East and Africa Lenvatinib Sales by Type (2015-2019)
9.3.2 Middle East and Africa Lenvatinib Revenue by Type (2015-2019)
9.4 Middle East and Africa Lenvatinib Market Status by Downstream Industry (2015-2019)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF LENVATINIB
10.1 Global Economy Situation and Trend Overview
10.2 Lenvatinib Downstream Industry Situation and Trend Overview
CHAPTER 11 LENVATINIB MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Lenvatinib by Major Manufacturers
11.2 Production Value of Lenvatinib by Major Manufacturers
11.3 Basic Information of Lenvatinib by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Lenvatinib Major Manufacturer
11.3.2 Employees and Revenue Level of Lenvatinib Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 LENVATINIB MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Eisai Co.
12.1.1 Company profile
12.1.2 Representative Lenvatinib Product
12.1.3 Lenvatinib Sales, Revenue, Price and Gross Margin of Eisai Co.
12.2 Everest Medicines
12.2.1 Company profile
12.2.2 Representative Lenvatinib Product
12.2.3 Lenvatinib Sales, Revenue, Price and Gross Margin of Everest Medicines
12.3 Beacon Pharmaceuticals Limited
12.3.1 Company profile
12.3.2 Representative Lenvatinib Product
12.3.3 Lenvatinib Sales, Revenue, Price and Gross Margin of Beacon Pharmaceuticals Limited
12.4 Shilpa Medicare Ltd.
12.4.1 Company profile
12.4.2 Representative Lenvatinib Product
12.4.3 Lenvatinib Sales, Revenue, Price and Gross Margin of Shilpa Medicare Ltd.
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF LENVATINIB
13.1 Industry Chain of Lenvatinib
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF LENVATINIB
14.1 Cost Structure Analysis of Lenvatinib
14.2 Raw Materials Cost Analysis of Lenvatinib
14.3 Labor Cost Analysis of Lenvatinib
14.4 Manufacturing Expenses Analysis of Lenvatinib
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Lenvatinib in This Report
1.2 Commercial Types of Lenvatinib
1.2.1 4mg
1.2.2 10mg
1.3 Downstream Application of Lenvatinib
1.3.1 Hospital
1.3.2 Pharmacy
1.3.3 Other
1.4 Development History of Lenvatinib
1.5 Market Status and Trend of Lenvatinib 2015-2026
1.5.1 Global Lenvatinib Market Status and Trend 2015-2026
1.5.2 Regional Lenvatinib Market Status and Trend 2015-2026
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Lenvatinib 2015-2019
2.2 Sales Market of Lenvatinib by Regions
2.2.1 Sales Volume of Lenvatinib by Regions
2.2.2 Sales Value of Lenvatinib by Regions
2.3 Production Market of Lenvatinib by Regions
2.4 Global Market Forecast of Lenvatinib 2020-2026
2.4.1 Global Market Forecast of Lenvatinib 2020-2026
2.4.2 Market Forecast of Lenvatinib by Regions 2020-2026
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Lenvatinib by Types
3.2 Sales Value of Lenvatinib by Types
3.3 Market Forecast of Lenvatinib by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Lenvatinib by Downstream Industry
4.2 Global Market Forecast of Lenvatinib by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Lenvatinib Market Status by Countries
5.1.1 North America Lenvatinib Sales by Countries (2015-2019)
5.1.2 North America Lenvatinib Revenue by Countries (2015-2019)
5.1.3 United States Lenvatinib Market Status (2015-2019)
5.1.4 Canada Lenvatinib Market Status (2015-2019)
5.1.5 Mexico Lenvatinib Market Status (2015-2019)
5.2 North America Lenvatinib Market Status by Manufacturers
5.3 North America Lenvatinib Market Status by Type (2015-2019)
5.3.1 North America Lenvatinib Sales by Type (2015-2019)
5.3.2 North America Lenvatinib Revenue by Type (2015-2019)
5.4 North America Lenvatinib Market Status by Downstream Industry (2015-2019)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Lenvatinib Market Status by Countries
6.1.1 Europe Lenvatinib Sales by Countries (2015-2019)
6.1.2 Europe Lenvatinib Revenue by Countries (2015-2019)
6.1.3 Germany Lenvatinib Market Status (2015-2019)
6.1.4 UK Lenvatinib Market Status (2015-2019)
6.1.5 France Lenvatinib Market Status (2015-2019)
6.1.6 Italy Lenvatinib Market Status (2015-2019)
6.1.7 Russia Lenvatinib Market Status (2015-2019)
6.1.8 Spain Lenvatinib Market Status (2015-2019)
6.1.9 Benelux Lenvatinib Market Status (2015-2019)
6.2 Europe Lenvatinib Market Status by Manufacturers
6.3 Europe Lenvatinib Market Status by Type (2015-2019)
6.3.1 Europe Lenvatinib Sales by Type (2015-2019)
6.3.2 Europe Lenvatinib Revenue by Type (2015-2019)
6.4 Europe Lenvatinib Market Status by Downstream Industry (2015-2019)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Lenvatinib Market Status by Countries
7.1.1 Asia Pacific Lenvatinib Sales by Countries (2015-2019)
7.1.2 Asia Pacific Lenvatinib Revenue by Countries (2015-2019)
7.1.3 China Lenvatinib Market Status (2015-2019)
7.1.4 Japan Lenvatinib Market Status (2015-2019)
7.1.5 India Lenvatinib Market Status (2015-2019)
7.1.6 Southeast Asia Lenvatinib Market Status (2015-2019)
7.1.7 Australia Lenvatinib Market Status (2015-2019)
7.2 Asia Pacific Lenvatinib Market Status by Manufacturers
7.3 Asia Pacific Lenvatinib Market Status by Type (2015-2019)
7.3.1 Asia Pacific Lenvatinib Sales by Type (2015-2019)
7.3.2 Asia Pacific Lenvatinib Revenue by Type (2015-2019)
7.4 Asia Pacific Lenvatinib Market Status by Downstream Industry (2015-2019)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Lenvatinib Market Status by Countries
8.1.1 Latin America Lenvatinib Sales by Countries (2015-2019)
8.1.2 Latin America Lenvatinib Revenue by Countries (2015-2019)
8.1.3 Brazil Lenvatinib Market Status (2015-2019)
8.1.4 Argentina Lenvatinib Market Status (2015-2019)
8.1.5 Colombia Lenvatinib Market Status (2015-2019)
8.2 Latin America Lenvatinib Market Status by Manufacturers
8.3 Latin America Lenvatinib Market Status by Type (2015-2019)
8.3.1 Latin America Lenvatinib Sales by Type (2015-2019)
8.3.2 Latin America Lenvatinib Revenue by Type (2015-2019)
8.4 Latin America Lenvatinib Market Status by Downstream Industry (2015-2019)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Lenvatinib Market Status by Countries
9.1.1 Middle East and Africa Lenvatinib Sales by Countries (2015-2019)
9.1.2 Middle East and Africa Lenvatinib Revenue by Countries (2015-2019)
9.1.3 Middle East Lenvatinib Market Status (2015-2019)
9.1.4 Africa Lenvatinib Market Status (2015-2019)
9.2 Middle East and Africa Lenvatinib Market Status by Manufacturers
9.3 Middle East and Africa Lenvatinib Market Status by Type (2015-2019)
9.3.1 Middle East and Africa Lenvatinib Sales by Type (2015-2019)
9.3.2 Middle East and Africa Lenvatinib Revenue by Type (2015-2019)
9.4 Middle East and Africa Lenvatinib Market Status by Downstream Industry (2015-2019)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF LENVATINIB
10.1 Global Economy Situation and Trend Overview
10.2 Lenvatinib Downstream Industry Situation and Trend Overview
CHAPTER 11 LENVATINIB MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Lenvatinib by Major Manufacturers
11.2 Production Value of Lenvatinib by Major Manufacturers
11.3 Basic Information of Lenvatinib by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Lenvatinib Major Manufacturer
11.3.2 Employees and Revenue Level of Lenvatinib Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 LENVATINIB MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Eisai Co.
12.1.1 Company profile
12.1.2 Representative Lenvatinib Product
12.1.3 Lenvatinib Sales, Revenue, Price and Gross Margin of Eisai Co.
12.2 Everest Medicines
12.2.1 Company profile
12.2.2 Representative Lenvatinib Product
12.2.3 Lenvatinib Sales, Revenue, Price and Gross Margin of Everest Medicines
12.3 Beacon Pharmaceuticals Limited
12.3.1 Company profile
12.3.2 Representative Lenvatinib Product
12.3.3 Lenvatinib Sales, Revenue, Price and Gross Margin of Beacon Pharmaceuticals Limited
12.4 Shilpa Medicare Ltd.
12.4.1 Company profile
12.4.2 Representative Lenvatinib Product
12.4.3 Lenvatinib Sales, Revenue, Price and Gross Margin of Shilpa Medicare Ltd.
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF LENVATINIB
13.1 Industry Chain of Lenvatinib
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF LENVATINIB
14.1 Cost Structure Analysis of Lenvatinib
14.2 Raw Materials Cost Analysis of Lenvatinib
14.3 Labor Cost Analysis of Lenvatinib
14.4 Manufacturing Expenses Analysis of Lenvatinib
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
